GeneType, Stayhealthy Announce Landmark Distribution Agreement For Multi-Risk Test To A Broader Audience In The Online Pharmacy Channel Across North America
GeneType, Stayhealthy Announce Landmark Distribution Agreement For Multi-Risk Test To A Broader Audience In The Online Pharmacy Channel Across North America
Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, and Stayhealthy, Inc., a leader in health and wellness technology, are excited to announce a major distribution agreement. This partnership will bring GTG's innovative Multi-Risk Test to a broader audience in the online pharmacy channel across North America, empowering individuals to take control of their health.
全球领先的基因技术公司Genetic Technologies Limited（ASX：GTG，纳斯达克：GENE，以下简称“GTG“）与健康和健身技术领域的领先企业Stayhealthy公司，兴奋宣布达成了一项重大的分销协议。本合作伙伴关系将会帮助GTG的创新型多风险检测仪器在北美在线药房渠道中覆盖更广泛的受众，使个人掌握自己的健康掌控权。
Stayhealthy is at the forefront of integrating technology with health solutions. The company's mission is to empower, inspire, and give hope to individuals, families, and communities through enhanced technology and a global wellness network. Their FDA-cleared technologies have enabled users to measure, track, and improve their health significantly.
Stayhealthy公司是将技术与健康解决方案紧密结合在一起的前沿企业，旨在通过增强技术和全球健康网络，为个人、家庭和社区带来授权、启发、希望。他们的获FDA认证的技术使用户显著提高了健康的衡量、跟踪和改善。